25P-NBOMe

Edit links
Source: Wikipedia, the free encyclopedia.
25P-NBOMe
Legal status
Legal status
Identifiers
  • 2-(4-propyl-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine
JSmol)
  • CCCC1=CC(OC)=C(CCNCC2=C(OC)C=CC=C2)C=C1OC
  • InChI=1S/C21H29NO3/c1-5-8-16-13-21(25-4)17(14-20(16)24-3)11-12-22-15-18-9-6-7-10-19(18)23-2/h6-7,9-10,13-14,22H,5,8,11-12,15H2,1-4H3 checkY
  • Key:QHEBYIJRKGDFGH-UHFFFAOYSA-N checkY

25P-NBOMe (2C-P-NBOMe, NBOMe-2C-P) is a derivative of the

5-HT2A receptor.[2][3] 25P-NBOMe has been sold as a drug and produces similar effects in humans to related compounds such as 25I-NBOMe and 25C-NBOMe
.

Legality

United Kingdom

This substance is a

Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[4]

See also

References

  1. ^ Anvisa (2023-07-24). "RDC Nº 804 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 804 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-07-25). Archived from the original on 2023-08-27. Retrieved 2023-08-27.
  2. PMID 24397362
    .
  3. doi:10.13140/RG.2.2.33671.14245
    .
  4. ^ "The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014". UK Statutory Instruments 2014 No. 1106. www.legislation.gov.uk.
Retrieved from "https://en.wikipedia.org/w/index.php?title=25P-NBOMe&oldid=1203382767"